Difficulty: Medium
Average Score: 63%
Practice
A patient of CHF was treated with furosemide and digoxin. He became symptom-free and is stable for 3 months. What is the next step?
Correct answer
B
Rationale
In this scenario, the correct answer is to continue all medications as before (Option B). This is the appropriate course of action because the patient is symptom-free and stable for 3 months on the current regimen of furosemide and digoxin. Discontinuing any of these medications could potentially lead to a recurrence of congestive heart failure (CHF) symptoms or destabilize the patient's condition.
Choosing option A, to stop the current medications and start an ACE inhibitor, is not the best choice at this point because the patient is already responding well to the current treatment regimen. Switching medications without a valid reason could disrupt the patient's stability.
Option C, to continue the diuretic but stop digoxin, is not recommended as digoxin is commonly used in the management of CHF to improve cardiac function and reduce symptoms. Stopping digoxin abruptly in a stable patient could lead to worsening of heart failure symptoms.
Option D, to continue digoxin but stop the diuretic, is also not the best choice because diuretics like furosemide are crucial in managing fluid overload in CHF patients. Stopping the diuretic could lead to fluid retention and exacerbation of CHF symptoms.
Educationally, this question highlights the importance of individualized patient care in managing CHF. It emphasizes the need to assess the patient's response to treatment before making any changes to their medication regimen. It also underscores the significance of understanding the mechanisms of action and indications for each medication in the treatment of CHF to make informed clinical decisions.
Choosing option A, to stop the current medications and start an ACE inhibitor, is not the best choice at this point because the patient is already responding well to the current treatment regimen. Switching medications without a valid reason could disrupt the patient's stability.
Option C, to continue the diuretic but stop digoxin, is not recommended as digoxin is commonly used in the management of CHF to improve cardiac function and reduce symptoms. Stopping digoxin abruptly in a stable patient could lead to worsening of heart failure symptoms.
Option D, to continue digoxin but stop the diuretic, is also not the best choice because diuretics like furosemide are crucial in managing fluid overload in CHF patients. Stopping the diuretic could lead to fluid retention and exacerbation of CHF symptoms.
Educationally, this question highlights the importance of individualized patient care in managing CHF. It emphasizes the need to assess the patient's response to treatment before making any changes to their medication regimen. It also underscores the significance of understanding the mechanisms of action and indications for each medication in the treatment of CHF to make informed clinical decisions.